During the SSS Holidays India Vizag 2023, Triple S VC announced its second investment of 2023 in a startup called Denovo Sciences – Armenian News

In the course of the SSS Holidays India Vizag 2023, Triple S VC introduced its second funding of 2023 in a startup known as Denovo Sciences, which is a deep expertise firm that creates novel therapeutics utilizing state-of-the-art AI applied sciences. 

The Denovo Platform is a breakthrough expertise which permits designing multi-target medicine which can be utilized to deal with advanced ailments, infectious ailments and most cancers concentrating on small molecules which may unlock an enormous house of drug targets/ailments that have been undruggable earlier than. Their expertise empowers scientists to work with all targets the place little or no dataset is out there.

Discovering new medicine can take 10 years and three bln {dollars} and in recent times there was an enormous curiosity from the pharma trade in utilizing AI to search out new drug candidates. However if you wish to develop a brand new drug candidate in opposition to a brand new goal/illness, often you don’t have sufficient knowledge to coach your algorithms on. ‘That’s why we’ve got constructed Denovo’s distinctive expertise that’s primarily based on reinforcement studying (a subtype of AI) which is dataset unbiased and is particularly designed to work with therapeutic targets which have little or no experimental knowledge obtainable’,  stated Hovakim Zakaryan, co-founder of the startup.

At the moment the workforce is specializing in the event of antiviral drug candidates in opposition to Hepatitis B virus, human coronaviruses and influenza viruses. Particularly, there’s no drug in opposition to continual hepatitis B virus and there are 300M individuals contaminated. ‘Denovo Sciences have created a novel resolution concentrating on a vital drawback within the drug discovery sector and I’m assured that the funding and partnership with Triple S VC will allow them to develop the corporate and advance their antiviral drug discovery initiatives’, stated Avag Simonyan the Managing Associate of the fund.

Triple S VC is a brand new enterprise fund co-founded by Artur Janibekyan, Avag Simonyan and Hakob Hakobyan in 2022 that targets startups in pre-seed and seed-stages.